Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA483406
Max Phase: Preclinical
Molecular Formula: C17H23N5O
Molecular Weight: 313.40
Molecule Type: Small molecule
Associated Items:
ID: ALA483406
Max Phase: Preclinical
Molecular Formula: C17H23N5O
Molecular Weight: 313.40
Molecule Type: Small molecule
Associated Items:
Synonyms (1): UR-AK24
Synonyms from Alternative Forms(1):
Canonical SMILES: CC(CC(=O)/N=C(\N)NCCCc1c[nH]cn1)c1ccccc1
Standard InChI: InChI=1S/C17H23N5O/c1-13(14-6-3-2-4-7-14)10-16(23)22-17(18)20-9-5-8-15-11-19-12-21-15/h2-4,6-7,11-13H,5,8-10H2,1H3,(H,19,21)(H3,18,20,22,23)
Standard InChI Key: NTHUVTORAXKPJS-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 313.40 | Molecular Weight (Monoisotopic): 313.1903 | AlogP: 1.97 | #Rotatable Bonds: 7 |
Polar Surface Area: 96.16 | Molecular Species: BASE | HBA: 2 | HBD: 3 |
#RO5 Violations: 0 | HBA (Lipinski): 6 | HBD (Lipinski): 4 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: 8.97 | CX LogP: 1.36 | CX LogD: -0.14 |
Aromatic Rings: 2 | Heavy Atoms: 23 | QED Weighted: 0.41 | Np Likeness Score: -0.55 |
1. Igel P, Schneider E, Schnell D, Elz S, Seifert R, Buschauer A.. (2009) N(G)-acylated imidazolylpropylguanidines as potent histamine H4 receptor agonists: selectivity by variation of the N(G)-substituent., 52 (8): [PMID:19317445] [10.1021/jm9000693] |
2. Ghorai P, Kraus A, Keller M, Götte C, Igel P, Schneider E, Schnell D, Bernhardt G, Dove S, Zabel M, Elz S, Seifert R, Buschauer A.. (2008) Acylguanidines as bioisosteres of guanidines: NG-acylated imidazolylpropylguanidines, a new class of histamine H2 receptor agonists., 51 (22): [PMID:18950149] [10.1021/jm800841w] |
3. Igel P, Dove S, Buschauer A.. (2010) Histamine H4 receptor agonists., 20 (24): [PMID:21044842] [10.1016/j.bmcl.2010.10.041] |
4. Geyer R, Igel P, Kaske M, Elz S, Buschauer A. (2014) Synthesis, SAR and selectivity of 2-acyl- and 2-cyano-1-hetarylalkyl-guanidines at the four histamine receptor subtypes: a bioisosteric approach, 5 (1): [10.1039/C3MD00245D] |
Source(1):